The CD26+ cancer cells also had elevated expression of prostate cancer-associated genes AMACR (α-methylacyl-CoA racemase), HPN (hepsin) and PCA3 (prostate cancer antigen 3). This evidence concerns the gene HPN and prostate carcinoma.